GoodRx (NASDAQ:GDRX) Stock Price Up 5.8% - Should You Buy?

GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) shot up 5.8% during trading on Friday . The company traded as high as $4.54 and last traded at $4.53. 660,285 shares changed hands during mid-day trading, a decline of 39% from the average session volume of 1,087,214 shares. The stock had previously closed at $4.28.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on GDRX shares. Citigroup lowered their price target on GoodRx from $7.00 to $6.25 and set a "buy" rating for the company in a research note on Friday. Morgan Stanley reduced their target price on GoodRx from $7.00 to $6.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Barclays decreased their target price on GoodRx from $10.00 to $6.00 and set an "overweight" rating for the company in a research note on Monday, November 11th. KeyCorp cut their price objective on GoodRx from $7.00 to $6.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, Mizuho started coverage on GoodRx in a research note on Wednesday, December 4th. They set a "neutral" rating and a $5.00 target price for the company. Five research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $8.38.

GoodRx Trading Up 6.3 %

The company has a market cap of $1.73 billion, a P/E ratio of -151.67, a PEG ratio of 3.43 and a beta of 1.27. The company has a current ratio of 5.48, a quick ratio of 5.48 and a debt-to-equity ratio of 0.70. The business has a 50 day moving average price of $4.75 and a 200-day moving average price of $6.59.

Institutional Trading of GoodRx

Several institutional investors and hedge funds have recently bought and sold shares of the business. Rubric Capital Management LP raised its stake in GoodRx by 25.2% in the 3rd quarter. Rubric Capital Management LP now owns 4,680,028 shares of the company's stock valued at $32,479,000 after acquiring an additional 943,226 shares during the period. Millennium Management LLC raised its position in shares of GoodRx by 36.5% in the second quarter. Millennium Management LLC now owns 4,121,939 shares of the company's stock valued at $32,151,000 after purchasing an additional 1,102,758 shares during the period. American Century Companies Inc. acquired a new stake in shares of GoodRx during the 2nd quarter worth about $18,183,000. Point72 Asset Management L.P. bought a new stake in shares of GoodRx during the 3rd quarter worth about $11,295,000. Finally, Geode Capital Management LLC grew its stake in GoodRx by 6.3% in the 3rd quarter. Geode Capital Management LLC now owns 982,729 shares of the company's stock valued at $6,823,000 after buying an additional 58,610 shares during the last quarter. Institutional investors own 63.77% of the company's stock.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.